JP2008525358A5 - M3ムスカリン受容体としてのピロリジニウム誘導体 - Google Patents

M3ムスカリン受容体としてのピロリジニウム誘導体 Download PDF

Info

Publication number
JP2008525358A5
JP2008525358A5 JP2007547367A JP2007547367A JP2008525358A5 JP 2008525358 A5 JP2008525358 A5 JP 2008525358A5 JP 2007547367 A JP2007547367 A JP 2007547367A JP 2007547367 A JP2007547367 A JP 2007547367A JP 2008525358 A5 JP2008525358 A5 JP 2008525358A5
Authority
JP
Japan
Prior art keywords
muscarinic receptors
pyrrolidinium derivatives
pyrrolidinium
derivatives
muscarinic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007547367A
Other languages
English (en)
Other versions
JP2008525358A (ja
Filing date
Publication date
Priority claimed from GBGB0428416.2A external-priority patent/GB0428416D0/en
Application filed filed Critical
Publication of JP2008525358A publication Critical patent/JP2008525358A/ja
Publication of JP2008525358A5 publication Critical patent/JP2008525358A5/ja
Pending legal-status Critical Current

Links

JP2007547367A 2004-12-24 2005-12-22 M3ムスカリン受容体としてのピロリニジウム誘導体 Pending JP2008525358A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0428416.2A GB0428416D0 (en) 2004-12-24 2004-12-24 Organic compounds
PCT/EP2005/013896 WO2006066928A1 (en) 2004-12-24 2005-12-22 Pyrrolinidium derivatives as m3 muscarinic receptors

Publications (2)

Publication Number Publication Date
JP2008525358A JP2008525358A (ja) 2008-07-17
JP2008525358A5 true JP2008525358A5 (ja) 2009-02-12

Family

ID=34130966

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007547367A Pending JP2008525358A (ja) 2004-12-24 2005-12-22 M3ムスカリン受容体としてのピロリニジウム誘導体

Country Status (16)

Country Link
US (1) US8383625B2 (ja)
EP (1) EP1831202B1 (ja)
JP (1) JP2008525358A (ja)
KR (1) KR101256242B1 (ja)
CN (1) CN101087777B (ja)
AT (1) ATE541839T1 (ja)
AU (1) AU2005318423B2 (ja)
BR (1) BRPI0519208A2 (ja)
CA (1) CA2589744C (ja)
ES (1) ES2377486T3 (ja)
GB (1) GB0428416D0 (ja)
MX (1) MX2007007720A (ja)
PL (1) PL1831202T3 (ja)
PT (1) PT1831202E (ja)
RU (1) RU2412183C2 (ja)
WO (1) WO2006066928A1 (ja)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1957451B1 (en) 2005-11-10 2011-10-19 Nicholas S. Bodor Soft anticholinergic zwitterions
CA2627982C (en) 2005-11-10 2013-09-10 Nicholas S. Bodor Soft anticholinergic esters
TW200825084A (en) 2006-11-14 2008-06-16 Astrazeneca Ab New compounds 521
WO2008103426A1 (en) 2007-02-23 2008-08-28 Theravance, Inc. Quaternary ammonium diphenylmethyl compounds useful as muscarinic receptor antagonists
SI2197841T1 (sl) 2007-09-07 2012-02-29 Theravance Inc Spojine, ki vsebujejo gvanidin, uporabne kot antagonisti muskarinskih receptorjev
JP2011506477A (ja) 2007-12-14 2011-03-03 セラヴァンス, インコーポレーテッド ムスカリン受容体拮抗薬として有用なアミジン含有化合物
EP2300464A1 (en) 2008-05-13 2011-03-30 AstraZeneca AB Quinuclidine derivatives as muscarinic m3 receptor antagonists
WO2014097151A2 (en) 2012-12-19 2014-06-26 Novartis Ag Autotaxin inhibitors
US9220707B2 (en) 2013-03-15 2015-12-29 Bodor Laboratories, Inc. Method of dosing and use of soft anticholinergic esters
US20150259283A1 (en) 2014-03-13 2015-09-17 Brickell Biotech, Inc. Formulation for soft anticholinergic analogs
US20170037030A1 (en) 2014-04-24 2017-02-09 Novartis Ag Autotaxin inhibitors
CN108137612A (zh) 2015-07-21 2018-06-08 博多尔实验仪器公司 软性抗胆碱能药类似物的制剂
TWI767507B (zh) 2016-07-21 2022-06-11 美商波德實驗股份有限公司 軟性抗膽鹼類似物之製劑

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL195520B1 (pl) * 1996-11-11 2007-09-28 Meda Pharma Gmbh & Co Kg Enancjomerycznie czyste estry, farmaceutycznie dopuszczalna sól, sposób wytwarzania, środek leczniczy i zastosowanie enancjomerycznie czystych estrów
CA2415468A1 (en) 2000-07-11 2003-01-10 Yoshio Ogino Ester derivatives
ES2206021B1 (es) * 2002-04-16 2005-08-01 Almirall Prodesfarma, S.A. Nuevos derivados de pirrolidinio.
AR044134A1 (es) * 2003-05-02 2005-08-24 Novartis Ag Derivados de quinuclidina, metodo de preparacion y composiciones farmaceuticas.
AR044851A1 (es) 2003-06-24 2005-10-05 Novartis Ag Compuestos heterociclicos, antagonistas del receptor m3 muscarinico
GB0428418D0 (en) 2004-12-24 2005-02-02 Novartis Ag Organic compounds
EP2227234B1 (en) * 2007-10-15 2014-05-07 Can-Fite Biopharma Ltd. Method for inducing hepatocyte proliferation and uses thereof

Similar Documents

Publication Publication Date Title
JP2008525358A5 (ja) M3ムスカリン受容体としてのピロリジニウム誘導体
CY2013047I1 (el) Ενωσεις διαρυλυδαντοϊνης
NO20055709D0 (no) Toppmontert boremaskin
NO20084803L (no) organiske forbindelser
BRPI0718874A2 (pt) Compostos orgânicos
BRPI0718478A2 (pt) Compostos orgânicos
DK1704797T3 (da) Arbejdsbord
ATE487691T1 (de) Acetylenderivate
DE602006015607D1 (de) Thiazol-4-carboxamid-derivate als mglur5-antagonisten
NO20055686D0 (no) Sammensetning
DE502005004675D1 (de) Organisches Bauelement
DK1937650T3 (da) Heterocykliske forbindelser
ATE443056T1 (de) Substituierte n-sulfonylaminophenylethyl-2- phenoxyacetamidverbindungen
CR10049A (es) Derivados de tiadiazol como agentes antidiabéticos
DE602006010581D1 (de) 4-phenyl-6-substituierte pyrimidin-2-carbonitrilderivate
BRPI0712902A2 (pt) compostos orgânicos
ATE485294T1 (de) Azaindol-2-carboxamid-derivate
FR2895386B1 (fr) Plieuse
ATE527255T1 (de) Aryl-isoxazol-4-yl-imidazol-derivate
DK1971588T3 (da) Tiglien-3-onderivater
DK1812448T3 (da) Organiske forbindelser
DE602006015186D1 (de) Oxindole als kinaseinhibitoren
DE602006014973D1 (de) Neuartige cercosporamidderivate
ATE541837T1 (de) Oxaphenanthren-derivate
DE602006015023D1 (de) Vergaser